Just Published

Childhood Faith Tied to Later Life Mixed Health Outcomes
news

October 28, 2025

A new international study finds that people raised with religion tend to report slightly poorer overall health in later life.
Stable Outcomes Seen in Transition to Xanomeline-Trospium Therapy for Schizophrenia
news

October 28, 2025

Patients with stable schizophrenia can switch to xanomeline–trospium without symptom worsening, highlighting a new treatment option with a novel mechanism.
Real-World Transition Strategies for Initiating Xanomeline–Trospium in Schizophrenia
news

October 28, 2025

Clinicians are using gradual cross-titration when switching to xanomeline–trospium for schizophrenia, achieving symptom control with manageable side effects.
PCC
Choosing a Pharmacologic Strategy for Psychosis
Rounds in the General Hospital

October 28, 2025

If you have ever wondered which antipsychotic agent to prescribe to your patient with psychosis or struggled to balance the concepts of efficacy, tolerability, and cost, then this case…
, , , et al
Serial Ketamine Infusions Fail to Outperform Placebo in New Trial
news

October 27, 2025

A new clinical trial found that repeated ketamine infusions offered no meaningful advantage over an active placebo for depression patients.
JCP
Brief Video Intervention to Increase Treatment-Seeking Intentions in Young Adults
Original Research

October 27, 2025

This brief video intervention was associated with greater increases in treatment-seeking intentions in people with self-reported psychiatric symptoms who were not previously engaged in the mental healthcare system and…
, , , et al

Explore
By Topic

View all topics
Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Front of Mind News

AI Counselors Cross Ethical Lines

Recent Features

Promotional image for PsychCase360 featuring headshots of Roueen Rafeyan, MD, and Melissa Vitale, PMHNP, with the title “Choosing the Right LAI for Patients With Schizophrenia.” A “WATCH NOW” button is below.
Figure shows a hand holding a vial and syringe above report title on PK of aripiprazole LAIs as described in JCP.
A smiling man in a pink suit jacket and colorful bow tie is pictured above text promoting an academic highlight on Dysregulation of Noradrenergic Activity, featuring Dr. Rakesh Jain and an expert consensus report.
Figure: Poster for virtual CME event, Next-Generation DMD Care, Oct 30, shows a person in a wheelchair and a Register button.

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals.

View JCP Articles
JCP
Evaluating the Transfer of Lurasidone Into Human Milk
Original Research

October 22, 2025

The relative infant dose of lurasidone, 1.16%, is below the standard 10% threshold for infant safety.
, ,
JCP
Autoimmune Diseases, Treatments, and Dementia Risk: A Population-Based Case-Control Study from Taiwan
Original Research

October 15, 2025

Thirteen autoimmune diseases were linked with an elevated dementia risk, particularly Behçet’s disease, multiple sclerosis, and lupus. Associations with vascular dementia were stronger than with Alzheimer’s disease.
, , , et al

Explore Special Sections from JCP

Focus on Childhood and Adolescent Mental Health Early Career Psychiatrists Focus on Geriatric Psychiatry Focus on Psychosis Focus on Psychotherapy Focus on Suicide Focus on Women’s Mental Health

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles
PCC
Impact of Hypotension on Cognitive Function
Rounds in the General Hospital

October 23, 2025

Hypotension acts synergistically to affect mental status by compounding problems with gas exchange, neurovascular dynamics, neuronal metabolism, and neurotoxicity.
, , , et al
PCC
Neuropsychiatric Challenges of Friedreich’s Ataxia
Case Report

October 23, 2025

Management of behavioral symptoms in Friedreich’s ataxia patients requires a nuanced approach that integrates psychiatric care with traditional neurological treatment.
, ,
CME Logo

Recent CME Institute Activities

2025 Manuscript Peer Review for Physicians Postgraduate Press, Inc. (The Journal of Clinical Psychiatry | The Primary Care Companion for CNS Disorders)

Evaluating the Old and New in Alzheimer’s Disease: Today’s Options for Improving Diagnosis and Treatment

Alzheimer’s Disease: New Paths to Treatment

Staying Up to Date in Perinatal Depression: Pathophysiology and Treatment Research

Neuropsychiatric Complications of Parkinson’s Disease Psychosis

Assessing Progress in FSHD Treatment Options: Unraveling Challenges and Measuring Outcomes

ASCP - American Society of Clinical Psychopharmacology logo

Read articles from ASCP Corner

ASCP Corner

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe